ClinicalTrials.Veeva

Menu

Sequence of Vessel Interruption and Circulating Tumor Cells in Surgical Lung Cancer (CTC-01)

L

Laval University

Status

Not yet enrolling

Conditions

Surgery
Lung Cancer
Circulating Tumor Cell

Treatments

Procedure: Arteries interruption before vein interruption
Procedure: Vein interruption before any other surgical manipulation

Study type

Interventional

Funder types

Other

Identifiers

NCT03645252
2019-2997, 21621

Details and patient eligibility

About

This study aims to define the impact of the sequence of vessel interruption on change in CTC and CTC clusters density in the tumor-draining pulmonary vein between the period before surgical manipulation and before tumor-draining vein interruption.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • NSCLC with preoperative pathological evidence,
  • Pure solid nodule or part-solid (>50%) ground glass nodule on CT scan
  • Clinical stage tumor-1 to 3, clinical stage node-0, clinical stage metastasis-0, (except clinical stage tumor-3 for chest wall, pericardium or phrenic nerve invasion)
  • Video-assisted thoracoscopic lobectomy or bi-lobectomy

Exclusion criteria

  • Pneumonectomy, segmentectomy, non anatomic resection
  • History of thoracic surgery on the same side
  • Necessity to perform a non-anatomic resection in addition to the lobectomy
  • No preoperative histological diagnosis
  • Pure ground glass nodule on CT scan
  • Clinical stage tumor-4 or 3 for chest wall, pericardium or phrenic nerve invasion
  • Clinical stage node ≥1
  • Neoadjuvant therapy
  • Second cancer or cancer in the past 5 years
  • First approach through thoracotomy with ribs spreading
  • Pregnancy, <18 years of age
  • Pulmonary adherences/symphysis found during surgery (impossible to perform the first blood sample without lung manipulation)

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

Vein first
Active Comparator group
Description:
Tumor-draining pulmonary vein is interrupted first and before any surgical manipulation.
Treatment:
Procedure: Vein interruption before any other surgical manipulation
Arteries before vein
Active Comparator group
Description:
Lobar arteries (+/- bronchus and inter-lobar fissures) are interrupted before tumor-draining pulmonary vein.
Treatment:
Procedure: Arteries interruption before vein interruption

Trial contacts and locations

1

Loading...

Central trial contact

Conti Massimo, MD; Marie-Hélène Lavoie

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems